GO Therapeutics
- Biotech or pharma, therapeutic R&D
GO Therapeutics is the leader in discovering and developing antibodies to clean glycoprotein solid tumor targets. GO’s glycoprotein targets are expressed only on the surface of cancer cells and not on healthy normal cells, providing clean access and delivery of potent anti-cancer therapeutics with high therapeutic index. GO is developing a portfolio of next-generation ADCs targeting this class of novel tumor antigens.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}